LLY-284
Maidir le taighde eolaíoch amháin, ní le haghaidh othar.
Sonraí Táirge
Clibeanna Táirge
| Méid Pacáiste | Infhaighteacht | Praghas (USD) |
| 0.1G | I Stoc | 350 |
| 0.5G | I Stoc | 750 |
| 1G | I Stoc | 910 |
Ainm Cheimiceach:
7H- Pirróló[2,3-d]pirimidin-4-aimín, 7-[(5S)-5-C-feinil-β-D- ribofuranóisil]-
Cód Smiles:
O[C@H]1[C@H](N2C3C(=C(N=CN=3)N)C=C2)O[C@]([H])([C@H](O) C2C=CC=CC=2)[C@H]1O
Cód InChi:
InChI=1S/C17H18N4O4/c18-15-10-6-7-21(16(10)20-8-19-15)17-13(24)12(23)14(25-17)11(22) 9-4-2-1-3-5-9/h1-8,11-14,17,22-24H,(H2,18,19,20)/t11-,12-,13+,14+, 17+/m0/s1
Eochair InChi:
WWOOWAHTEXIWBO-CNUPYSBSA-N
Eochairfhocal:
2226515-75-7; CAS:2226515-75-7
Tuaslagthacht:
Stóráil:
Cur síos:
Is inhibitor éifeachtach PRMT5 é LLY-283.
Sprioc: PRMT5


![3-clóra-2-(10-fluara-8-(prop-1-yn-1-il)-1,2,3,4,12,12a-heicseahidr-6H-beansó[f]pirazino[2,1 -c][1,4]oxazepin-9-il)feanól](http://www.caerulumpharm.com/uploads/20240722105749.jpg)
![1H-Pirazolo[3,4-d]pirimidín, 6-clóra-1-[[4-[1-(1-meitileitile)-4-(trífhluaramethyl)-1H-imidazol-2-il]feinil]meitil]-](http://www.caerulumpharm.com/uploads/20240603134133.jpg)

![4H-1,3-Dé-ocsól[4,5-c]pioról-4-aigéad carbocsaileach, teitrihidre-2,2-démheitil-6-ocsa-, (3aS,4S,6aS)-](http://www.caerulumpharm.com/uploads/20241023143839.jpg)

